Pateres, Mhark Ghiell R.
HRN: 22-24-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/14/2023
01/20/2023
IVT
15mg
Q24 X 7 Days
Pneumonia; Liver Pathology
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes